The 2D Pilot Line (2D-PL), a Graphene Flagship project dedicated to industrialising graphene and other 2D materials for semiconductor applications, announces the launch of its fourth multi-project wafer (MPW) run, marking another milestone in Europe’s growing ecosystem for 2D-material-based device fabrication.
Graphenea Semiconductor, a leading graphene foundry company and partner in the Graphene Flagship's 2D Pilot Line project and Melexis, a global supplier of micro-electronic semiconductor solutions, announces a strategic collaboration to accelerate the development and evaluation of Melexis’ integrated GFET-on-CMOS platform for advanced biosensing.
Recent research on various biomarkers for major depressive disorder (MDD) provide an opportunity to develop biosensors that can overcome the challenges faced by conventional diagnostic tools, MUNASET researchers say.
Multi project wafer (MPW) runs are a common practice within the semiconductor ecosystem. Universities, R&D centres and start ups, which usually only need a few prototypes and operate with tight budgets, take advantage of this service to obtain devices at an affordable entry point. This is carried out with a mask sharing scheme, where devices with different geometries but shared device architecture are manufactured within the same mask; in this way, everyone gets a few devices but no one needs to purchase more devices than necessary. Now, Graphenea partners with the 2D Experimental Pilot Line (2D-EPL) to offer an MPW run with a novel process flow.
The new biosensor looks like a small box connected to a mobile phone. This device can immediately detect even very small antibiotic residues, namely ampicillin, in water or dairy products.
Graphene Flagship Spearhead Project AUTOVISION is developing a new high-resolution image sensor for autonomous vehicles, which can detect obstacles and road curvature even in extreme and difficult driving conditions.